These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2834914

  • 1. Hypothermia induced by WR-2721 in the rat.
    Benova D, Kiradzhiev G, Nikolova MA.
    Acta Physiol Pharmacol Bulg; 1987; 13(4):60-5. PubMed ID: 2834914
    [Abstract] [Full Text] [Related]

  • 2. [Investigations with beagles about toxicity and radioprotective effect of the clinical radioprotection substance WR 2721. Part I. Toxicity of WR 2721 (author's transl)].
    Wagner M, Sedlmeier H, Wustrow T, Messerschmidt O.
    Strahlentherapie; 1980 Jul; 156(7):486-91. PubMed ID: 6258271
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
    Yuhas JM, Culo F.
    Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
    [Abstract] [Full Text] [Related]

  • 6. Behavioral toxicity and efficacy of WR-2721 as a radioprotectant.
    Bogo V, Jacobs AJ, Weiss JF.
    Radiat Res; 1985 Nov; 104(2 Pt 1):182-90. PubMed ID: 3001816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of area postrema lesions on taste aversions produced by treatment with WR-2721 in the rat.
    Rabin BM, Hunt WA, Lee J.
    Neurobehav Toxicol Teratol; 1986 Nov; 8(1):83-7. PubMed ID: 3010144
    [Abstract] [Full Text] [Related]

  • 12. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
    Milas L, Ito H, Hunter N.
    Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
    [Abstract] [Full Text] [Related]

  • 13. Short-term radioprotective effects of WR-2721 on the rat parotid glands.
    Sodicoff M, Conger AD, Trepper P, Pratt NE.
    Radiat Res; 1978 Aug; 75(2):317-26. PubMed ID: 213806
    [No Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro effects of WR-2721 in experimental hypercalcemia in the rat.
    Weiss J, Walker ST, Fallon M, Goldfarb S.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):969-73. PubMed ID: 3018229
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of reduction in the testicular weight by WR-2721 in relation to the body weight after whole-body gamma irradiation.
    Bhartiya HC, Jaimala.
    Strahlenther Onkol; 1986 Jan; 162(1):68-70. PubMed ID: 3003944
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of radiation carcinogenesis in mice by S-2-(3-aminopropylamino)-ethylphosphorothioic acid.
    Milas L, Hunter N, Stephens LC, Peters LJ.
    Cancer Res; 1984 Dec; 44(12 Pt 1):5567-9. PubMed ID: 6093999
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D, Bensely D, Schein P.
    Cancer Res; 1994 Feb 01; 54(3):738-41. PubMed ID: 8306335
    [Abstract] [Full Text] [Related]

  • 20. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
    Steel LK, Jacobs AJ, Giambarresi LI, Jackson WE.
    Radiat Res; 1987 Mar 01; 109(3):469-78. PubMed ID: 3031721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.